| Code | CSB-MP854680MOV-B |
| Abbreviation | Recombinant Cynomolgus monkey FCGR3A protein, partial, Biotinylated (Active) |
| MSDS | |
| Size | $9.9 |
| Promotion | |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CD16a mediates antibody-dependent cellular cytotoxicity by bridging IgG-opsonized targets to NK cells and macrophages, making it a critical node in therapeutic antibody efficacy and immune surveillance studies. This cynomolgus macaque ortholog, spanning the extracellular domain (aa 17–208) and expressed in mammalian cells to preserve native glycosylation patterns, demonstrates quantifiable binding to an anti-FCGR3A antibody with an EC50 of 14.09–25.58 ng/ml in functional ELISA, confirming conformational integrity suitable for ligand-binding assays, competitive inhibition screens, and therapeutic antibody epitope mapping. The site-specific biotinylation via C-terminal Avi-tag enables direct immobilization in SPR and BLI platforms for affinity characterization of antibody-Fc variants or blocking candidates without compromising the receptor's binding interface. Purity exceeding 95% and endotoxin below 1.0 EU/μg align with standards expected in antibody-dependent cellular cytotoxicity mechanism studies and biologic inhibitor screening workflows.
There are currently no reviews for this product.
KEGG: mcf:102140945
UniGene: Mfa.6130